The Latest Breaking News from Colon Cancer

A study has tied a substance in the blood to colorectal cancer in people under age 50. It may act as an early signal of the disease, scientists say, but that needs to be confirmed.

With the FDA's approval, it is very likely that private insurance companies and Medicare will cover the cost of the blood test, making it more accessible for patients.

FDA approves Guardant's Shield test for colon cancer screening in adults aged 45 and above, providing a convenient and accessible method for early detection.

Learn about the concerning surge in colon cancer rates among young adults, linked to diet and lifestyle factors. Screening guidelines have been revised to ...

Six dogs are being trained to detect colon cancer from urine samples.

More than 53,000 Americans are projected to die from colorectal cancer this year. Although colorectal cancer is the second-most common cause of cancer deaths in the United States, it can be cured if caught early. Detecting a tumor as soon as possible can help you get treatment as soon as…

Guardant Health stock jumped Friday after an FDA panel recommended the agency approval Guardant's blood-based colon cancer screening test.

Nationwide colorectal cancer incidence and mortality rates have fallen since 2000, but rates have been increasing among younger adults for several years.

Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.

Learn about promising advancements in colon cancer screening methods, including new blood tests and improved stool tests, offering hope for increased early...

The Cologuard Classic combines golf and advocacy to raise awareness about colon cancer screening, featuring top players and supporting survivors.